Medications for Chronic Spontaneous Urticaria

2 results

  • dupixent

    (Dupilumab)
    sanofi-aventis U.S. LLC
    DUPIXENT is indicated for treating moderate-to-severe atopic dermatitis in patients 6 months and older, asthma in patients 6 years and older, chronic rhinosinusitis with nasal polyps in patients 12 and older, eosinophilic esophagitis, prurigo nodularis, inadequate COPD management, chronic spontaneous urticaria over 12, and bullous pemphigoid in adults.

  • xolair

    (omalizumab)
    Genentech, Inc.
    XOLAIR is indicated for adults and children 6 years and older with moderate to severe persistent asthma, chronic rhinosinusitis with nasal polyps in adults, IgE-mediated food allergies (ages 1+), and chronic spontaneous urticaria in those 12+ who do not respond to antihistamines. Not for acute symptoms or emergency use.